WG
The startup develops medical technology tools that analyze circulating cell-free DNA (cfDNA) in blood samples using multi-omics, molecular, and epigenetic methylation markers for colorectal cancer diagnosis. This system enhances the accuracy of pancreatic cancer detection and supports clinical trials by utilizing colon cancer clinical specimens.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops medical technology tools that analyze circulating cell-free DNA (cfDNA) in blood samples using multi-omics, molecular, and epigenetic methylation markers for colorectal cancer diagnosis. This system enhances the accuracy of pancreatic cancer detection and supports clinical trials by utilizing colon cancer clinical specimens.